IL274714A - Methods and materials for cancer assessment and treatment - Google Patents

Methods and materials for cancer assessment and treatment

Info

Publication number
IL274714A
IL274714A IL274714A IL27471420A IL274714A IL 274714 A IL274714 A IL 274714A IL 274714 A IL274714 A IL 274714A IL 27471420 A IL27471420 A IL 27471420A IL 274714 A IL274714 A IL 274714A
Authority
IL
Israel
Prior art keywords
assessing
materials
methods
treating cancer
cancer
Prior art date
Application number
IL274714A
Other languages
English (en)
Hebrew (he)
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of IL274714A publication Critical patent/IL274714A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/99—Isomerases (5.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL274714A 2017-11-20 2020-05-17 Methods and materials for cancer assessment and treatment IL274714A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762588654P 2017-11-20 2017-11-20
PCT/US2018/062007 WO2019100059A1 (en) 2017-11-20 2018-11-20 Methods and materials for assessing and treating cancer

Publications (1)

Publication Number Publication Date
IL274714A true IL274714A (en) 2020-07-30

Family

ID=64755707

Family Applications (1)

Application Number Title Priority Date Filing Date
IL274714A IL274714A (en) 2017-11-20 2020-05-17 Methods and materials for cancer assessment and treatment

Country Status (9)

Country Link
US (1) US20210063401A1 (ko)
EP (1) EP3714272A1 (ko)
JP (1) JP7312464B2 (ko)
KR (1) KR20200100644A (ko)
CN (1) CN111630385A (ko)
AU (1) AU2018370339A1 (ko)
CA (1) CA3083018A1 (ko)
IL (1) IL274714A (ko)
WO (1) WO2019100059A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110669104B (zh) * 2019-10-30 2021-11-05 上海交通大学 一组来源于人外周血单核细胞的标志物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003102018A2 (en) * 2002-06-03 2003-12-11 The Institute For Systems Biology Methods for quantitative proteome analysis of glycoproteins
EP1766408A2 (en) * 2004-07-09 2007-03-28 Tripath Imaging, Inc. Methods and compositions for the detection of ovarian cancer
WO2009075883A2 (en) * 2007-12-12 2009-06-18 University Of Georgia Research Foundation, Inc. Glycoprotein cancer biomarker
US20110190151A1 (en) * 2008-04-10 2011-08-04 Mcmanus Bruce Methods of diagnosing chronic cardiac allograft rejection
US9796761B2 (en) * 2009-07-14 2017-10-24 National Institute Of Advanced Industrial Science And Technology Glycan markers as measure of disease state of hepatic diseases
WO2013019634A1 (en) * 2011-07-29 2013-02-07 University Of Georgia Research Foundation, Inc. Alpha toxin detection of gpi anchored proteins
JP6082026B2 (ja) * 2011-12-21 2017-02-15 インテグレイティド ダイアグノスティクス，インコーポレイティド 肺癌診断用の組成物、方法及びキット
JP2016029335A (ja) * 2012-12-17 2016-03-03 国立研究開発法人医薬基盤・健康・栄養研究所 大腸がんの判定方法
US10126305B2 (en) * 2013-06-25 2018-11-13 University of Pittsburg—Of the Commonwealth System of Higher Education Proteomic biomarkers of sepsis in elderly patients

Also Published As

Publication number Publication date
EP3714272A1 (en) 2020-09-30
WO2019100059A1 (en) 2019-05-23
CA3083018A1 (en) 2019-05-23
JP2021503607A (ja) 2021-02-12
AU2018370339A1 (en) 2020-06-04
KR20200100644A (ko) 2020-08-26
CN111630385A (zh) 2020-09-04
JP7312464B2 (ja) 2023-07-21
US20210063401A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
IL272470A (en) Methods and materials for the evaluation and treatment of cancer
IL267247B (en) Compositions and methods for treating cancer
IL262225A (en) Methods for monitoring and treating cancer
IL269150A (en) Preparations and methods for the treatment of cancer
HK1253093A1 (zh) 診斷和治療癌症的方法
IL266053A (en) Preparations and methods for the treatment of ezh2-mediated cancer
IL263224A (en) Methods and preparations for the treatment of cancer
IL262223A (en) Methods for monitoring and treating cancer
IL269157A (en) Preparations and methods for the treatment of cancer
IL268985A (en) A method for evaluating and treating cellulite
EP3271483A4 (en) Methods and materials for assessing and treating cancer
IL282478A (en) Materials and methods for cancer treatment
IL288086A (en) Methods and materials for cancer treatment
PT3293201T (pt) Combinação de adenovírus e inibidores de ponto de verificação para tratamento do cancro
SG10202013112YA (en) Zinc-gamma-pga compositions and methods for treating cancer
EP3119427A4 (en) Methods and materials for treating cancer
EP3713478A4 (en) METHODS AND MATERIALS FOR EVALUATION AND TREATMENT OF OBESITAS
ZA201802618B (en) Anti-cd43 antibody and use thereof for cancer treatment
EP3519592A4 (en) MATERIALS AND METHODS FOR THE ASSESSMENT AND TREATMENT OF CANCER
EP3119426A4 (en) Methods and materials for treating cancer
EP3255994A4 (en) Methods and materials for assessing and treating arthritis
EP3568145A4 (en) MATERIALS AND METHODS FOR THE TREATMENT OF CANCER
IL272782A (en) Preparations and methods for the treatment of cancer
EP3672619A4 (en) MATERIALS AND METHODS FOR EVALUATING CANCER RISK AND TREATING CANCER
EP3273970A4 (en) Methods and materials for treating cancer